학술논문

Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression
Document Type
article
Source
Cell Reports. 19(4)
Subject
Biological Sciences
Human Genome
Cancer
Genetics
Aetiology
2.1 Biological and endogenous factors
Acetylation
Cell Line
Cell Proliferation
Chromatin
Chromatin Immunoprecipitation
Disease-Free Survival
Epigenomics
Histone Deacetylase Inhibitors
Histone Deacetylases
Histones
Humans
Hydroxamic Acids
Kaplan-Meier Estimate
Melanoma
PTEN Phosphohydrolase
Principal Component Analysis
RNA Interference
RNA
Small Interfering
Signal Transduction
Vorinostat
CBP
ChIP-seq
DUSP5
HDAC
chromatin state
epigenome
histone modifications
melanoma
Biochemistry and Cell Biology
Medical Physiology
Biological sciences
Language
Abstract
The extent and nature of epigenomic changes associated with melanoma progression is poorly understood. Through systematic epigenomic profiling of 35 epigenetic modifications and transcriptomic analysis, we define chromatin state changes associated with melanomagenesis by using a cell phenotypic model of non-tumorigenic and tumorigenic states. Computation of specific chromatin state transitions showed loss of histone acetylations and H3K4me2/3 on regulatory regions proximal to specific cancer-regulatory genes in important melanoma-driving cell signaling pathways. Importantly, such acetylation changes were also observed between benign nevi and malignant melanoma human tissues. Intriguingly, only a small fraction of chromatin state transitions correlated with expected changes in gene expression patterns. Restoration of acetylation levels on deacetylated loci by histone deacetylase (HDAC) inhibitors selectively blocked excessive proliferation in tumorigenic cells and human melanoma cells, suggesting functional roles of observed chromatin state transitions in driving hyperproliferative phenotype. Through these results, we define functionally relevant chromatin states associated with melanoma progression.